Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Cantor Fitzgerald
Deloitte
Moodys
Queensland Health
Healthtrust

Generated: September 24, 2019

DrugPatentWatch Database Preview

Patent: 10,092,645

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,092,645
Title:Methods of treatment with antagonists against PD-1 and PD-L1 in combination with radiation therapy
Abstract: This application provides a method of treating cancer in a patient comprising administering at least one dose of radiation therapy and at least one PD-1 and/or PD-L1 antagonist, wherein at least one PD-1 and/or PD-L1 antagonist is administered on the same day as a dose of radiation therapy or up to and including 4 days later.
Inventor(s): Stewart; Ross (Cambridge, GB), Morrow; Michelle (Cambridge, GB), Wilkinson; Robert (Cambridge, GB), Poon; Edmund (Cambridge, GB), Dovedi; Simon (Manchester, GB), Illidge; Tim (Manchester, GB)
Assignee: MedImmune Limited (Cambridge, GB)
Application Number:14/740,876
Patent Claims:see list of patent claims

Details for Patent 10,092,645

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck Sharp Dohme KEYTRUDA pembrolizumab POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER 125514 001 2014-09-04   Try a Free Trial MedImmune Limited (Cambridge, GB) 2034-06-17 RX Orphan search
Bristol Myers Squibb OPDIVO nivolumab INJECTABLE;INJECTION 125527 001 2015-03-04   Try a Free Trial MedImmune Limited (Cambridge, GB) 2034-06-17 RX search
Bristol Myers Squibb OPDIVO nivolumab INJECTABLE;INJECTION 125527 002 2015-03-04   Try a Free Trial MedImmune Limited (Cambridge, GB) 2034-06-17 RX search
Bristol Myers Squibb OPDIVO nivolumab INJECTABLE;INJECTION 125554 001 2015-11-23   Try a Free Trial MedImmune Limited (Cambridge, GB) 2034-06-17 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Covington
UBS
Deloitte
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.